JW Holdings wins $10 million drug contract

Published: 2013-01-23 06:57:00

Updated: 2013-01-23 06:57:00

JW Holdings has won a contract to supply $10 million worth of Q-roxin (balofloxacin), a quinolone antibiotic and hair dye Changpo(n) to the Chinese market, the Korean pharmaceutical firm said Monday.

The company said it signed an agreement with Tianjin Green Fine Pharma to exports Q-roxin from...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK